Consumer Research
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The past two weeks brought measurable movement ...
Congress Presses FDA on Psychedelic Therapy Approvals
WASHINGTON – A bipartisan coalition of 32 House members sent ...
Organigram Strikes Deal to Acquire Sanity Group
TORONTO-BERLIN – Organigram Global Inc. has signed a definitive agreement to purchase the remaining shares of Berlin-based Sanity Group GmbH that it does not already hold. The transaction builds on Organigram's earlier minority stake and ...
Innovia Consulting Acquires 365 Cannabis
ONALASKA – Innovia Consulting, a longtime provider of Microsoft Dynamics 365 Business Central services, has acquired 365 Cannabis along with its sister entity 365Vertical. The deal brings in two Microsoft partners that focus on customized ...
New 2026 Farm Bill Draft Targets Industrial Hemp Burdens
WASHINGTON – House Agriculture Committee Chairman Glenn Thompson (R-PA) introduced a new Farm Bill draft (Farm, Food, and National Security Act of 2026), proposing changes that would ease certain federal requirements for industrial hemp growers. ...
New York State OCM Updates Medical Cannabis Program, Expands Access for Out-of-State Patients
ALBANY – Governor Kathy Hochul signed a bill into law that extends New York's medical Cannabis program to patients certified in other states, marking the most substantial revision to the initiative since its 2016 launch. ...
New Brunswick Government Bets on Organigram with $2M Grant
MONCTON – Organigram Global Inc. has secured $2 million in provincial funding to support a $9.3 million project aimed at revamping its flagship cultivation site here. The upgrade, which targets lighting systems across 75 grow ...
Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone
DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 2025 sales for its cannabidiol-based epilepsy drug Epidiolex®, pushing the product's YTD revenue past $772 million and underscoring the company's steady position in the medical ...
Medicare Explores CBD Coverage for Seniors
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) is set to roll out a pilot program that could extend coverage to cannabidiol (CBD) treatments for certain older Americans, marking a cautious step by ...
CMS Finalizes Rule for Medicare CBD Coverage Pilot
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) has finalized regulations enabling a pilot program for federal health insurance coverage of hemp-derived CBD products, according to a recent statement from an executive at ...
Missouri Cannabis Sales Hit Record $1.5B in 2025
JEFFERSON CITY – Missouri's regulated Cannabis market posted its strongest year yet in 2025, with retailers recording approximately $1.5 billion in total sales, according to figures from the Missouri Department of Health and Senior Services. ...
New Hampshire House Advances Bill to Regulate Medical Psilocybin Use
CONCORD – The New Hampshire House of Representatives has given initial approval to a bipartisan measure that would establish a state program allowing supervised therapeutic access to psilocybin for qualifying medical conditions. House Bill 1809, ...
